Log in

NASDAQ:SBRAPSABRA HLTHCRE REIT 7.125% SRS A PRF Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$25.40
0.00 (0.00 %)
(As of 05/31/2018)
Add
Compare
Today's Range
$25.40
Now: $25.40
$25.43
50-Day Range
$25.40
MA: $25.40
$25.40
52-Week Range
$24.75
Now: $25.40
$26.61
Volume46,201 shs
Average Volume12,396 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
As of December 31, 2017, Sabra's investment portfolio included 507 real estate properties held for investment (consisting of (i) 384 Skilled Nursing/Transitional Care facilities, (ii) 88 Senior Housing - Leased communities, (iii) 13 Senior Housing - Managed communities and (iv) 22 Acute Care Hospitals), one investment in a direct financing lease, 22 investments in loans receivable (consisting of (i) two mortgage loans, (ii) two construction loans, (iii) two mezzanine loans, (iv) one pre-development loan and (v) 15 other loans), 12 preferred equity investments and one investment in a specialty valuation firm. As of December 31, 2017, Sabra's real estate properties held for investment included 53,558 beds/units, spread across the United States and Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.54 out of 5 stars


Industry, Sector and Symbol

Industry REIT - Healthcare Facilities
Sub-IndustryN/A
Current SymbolNASDAQ:SBRAP
CUSIPN/A
Phone+1-888-3938248

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive SBRAP News and Ratings via Email

Sign-up to receive the latest news and ratings for SBRAP and its competitors with MarketBeat's FREE daily newsletter.

SABRA HLTHCRE REIT 7.125% SRS A PRF (NASDAQ:SBRAP) Frequently Asked Questions

Has SABRA HLTHCRE REIT 7.125% SRS A PRF been receiving favorable news coverage?

Press coverage about SBRAP stock has been trending very negative on Sunday, InfoTrie Sentiment reports. The research group ranks the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. SABRA HLTHCRE REIT 7.125% SRS A PRF earned a media sentiment score of -3.2 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news about SABRA HLTHCRE REIT 7.125% SRS A PRF.

Who are some of SABRA HLTHCRE REIT 7.125% SRS A PRF's key competitors?

Who are SABRA HLTHCRE REIT 7.125% SRS A PRF's key executives?

SABRA HLTHCRE REIT 7.125% SRS A PRF's management team includes the following people:
  • Mr. Richard K. Matros, Chairman, Pres & CEO (Age 64)
  • Mr. Harold W. Andrews Jr., Exec. VP, CFO, Sec. & Principal Accounting Officer (Age 54)
  • Ms. Talya Nevo-Hacohen, Exec. VP, Chief Investment Officer & Treasurer (Age 58)
  • Mr. Peter W. Nyland, Exec. VP of Asset Management
  • Mr. Brent P. Chappell, Exec. VP & Portfolio Mang. (Age 53)

What is SABRA HLTHCRE REIT 7.125% SRS A PRF's stock symbol?

SABRA HLTHCRE REIT 7.125% SRS A PRF trades on the NASDAQ under the ticker symbol "SBRAP."

What is SABRA HLTHCRE REIT 7.125% SRS A PRF's stock price today?

One share of SBRAP stock can currently be purchased for approximately $25.40.

What is SABRA HLTHCRE REIT 7.125% SRS A PRF's official website?

The official website for SABRA HLTHCRE REIT 7.125% SRS A PRF is www.sabrahealth.com.

How can I contact SABRA HLTHCRE REIT 7.125% SRS A PRF?

SABRA HLTHCRE REIT 7.125% SRS A PRF's mailing address is 18500 von Karman Ave Ste 550, IRVINE, CA 92612-0539, United States. The company can be reached via phone at +1-888-3938248.

This page was last updated on 7/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.